Iqvia Holdings (IQV) Asset Writedowns and Impairment (2011)
Iqvia Holdings' (IQV) quarterly Asset Writedowns and Impairment came in at $12.2 million in Q4 2011.
Analysis
Iqvia Holdings (IQV) Asset Writedowns and Impairment (2011) Analysis & Trends
Iqvia Holdings has disclosed Asset Writedowns and Impairment across 1 years of filings, most recently posting $12.2 million for Q4 2011.
- In Q4 2011, Asset Writedowns and Impairment changed N/A year-over-year to $12.2 million; the TTM figure through Dec 2017 stood at $12.2 million (changed N/A YoY), while the FY2017 annual figure was $40.0 million, up 42.86% from the prior year.
- Asset Writedowns and Impairment came in at $12.2 million for Q4 2011 at Iqvia Holdings.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $12.2 million in Q4 2011 to a low of $12.2 million in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |